Targeted axillary dissection using carbon marking for patients with node-positive breast cancer following neoadjuvant therapy (TADCOM): study protocol for a prospective, multicenter, randomized controlled trial

Study Overview: Targeted Axillary Dissection with Carbon Marking for Breast Cancer

Background

Neoadjuvant chemotherapy (NAC) can help breast cancer patients with lymph node metastases achieve complete responses, possibly eliminating the need for extensive lymph node removal. Traditional methods for targeted axillary dissection (TAD) using tissue markers have issues like marker loss and high costs. A new method using carbon nanoparticle suspension injection (CNSI) could provide a more reliable solution, enhancing the TAD process. This study focuses on assessing various TAD techniques using CNSIs and their practical value in treating locally advanced breast cancer.

Methods

This study will include 126 patients diagnosed with breast cancer and suspicious lymph nodes who respond well to NAC. Participants will be divided into three groups to receive different TAD methods: 1. Conventional tissue clips (CG-TAD); 2. CNSI lymph node marking (CN-LNM); 3. Peritumoral CNSI mapping (PCN-MAP). Key measurements will include the success of retrieving marked lymph nodes, the number and agreement of sentinel and marked lymph nodes, and any complications that arise. Secondary measurements will look at recurrence rates, survival rates, surgical time, complications post-surgery, quality of life, and the status of tumor margins. We will follow strict statistical guidelines to ensure valid results.

Discussion

This study is designed to assess how effective and precise CNSI can be for targeted axillary dissection in breast cancer patients post-NAC. We aim to show how it can reduce surgery-related complications and costs while improving accuracy.

Trial Registration

Registered at Clinicaltrials.gov, NCT04744506 on December 27, 2020, with updates on September 24, 2024. Protocol Version Ver 1.2, dated September 17, 2024.

Importance of Clinical Trials

Clinical trials are vital for creating safe, effective treatments. Our AI platform, DocSym, streamlines access to clinical protocols and research to help clinicians implement these advances in everyday practice.

Enhancing Patient Care

In a fast-evolving healthcare landscape, operational efficiency is key. Our mobile apps assist with scheduling, treatment monitoring, and telemedicine, simplifying patient management and expanding digital services.

Boosting Clinic Efficiency

By leveraging AI technology, clinics can optimize workflows, enhance patient outcomes, and minimize paperwork. Discover more about our solutions at aidevmd.com.

AI Products for Business or Try Custom Development

AI Sales Bot

Welcome AI Sales Bot, your 24/7 teammate! Engaging customers in natural language across all channels and learning from your materials, it’s a step towards efficient, enriched customer interactions and sales

AI Document Assistant

Unlock insights and drive decisions with our AI Insights Suite. Indexing your documents and data, it provides smart, AI-driven decision support, enhancing your productivity and decision-making.

AI Customer Support

Upgrade your support with our AI Assistant, reducing response times and personalizing interactions by analyzing documents and past engagements. Boost your team and customer satisfaction

AI Scrum Bot

Enhance agile management with our AI Scrum Bot, it helps to organize retrospectives. It answers queries and boosts collaboration and efficiency in your scrum processes.